HEMICAP PATELLO-FEMORAL RESURFACING PROSTHESIS PX02-0218 / PX02-0705-W

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative report with the FDA on 2016-11-03 for HEMICAP PATELLO-FEMORAL RESURFACING PROSTHESIS PX02-0218 / PX02-0705-W manufactured by Arthrosurface, Inc..

Event Text Entries

[59123543] The exact reason for the metallosis is not known. According to arthrosurface engineering, the inner surface of the pfxl articular implant taper showed no signs of metal wear. However, wear/damage was noticed on the outer surface of the ti fixation components. From radiographs obtained, it cannot be confirmed, but it appears that the tapers were not seated properly, possibly from the initial implantation. As such, this may have caused rocking movement leading to the friction between both components. Review of the complaint history indicated no prior complaints for the part-lot combinations associated with the reported devices. Review of device history records (dhrs) identified no manufacturing deviations that would have caused or contributed to the reported issue. All arthrosurface hemicap implants undergo wear, corrosion and fretting tests as a part of their design and developmental stages. No occurences of material disintegration or decomposition have been reported in any arthrosurface hemicap implant history. Based on the information available, no further conclusions can be drawn. The complaint is considered closed at this time. Manufacturing and expiry dates of the implants under question are specified below part # px02-0705-w, lot # 75hb3020, mfg. Date: 08-2012, exp. Date: 08-2019. Part # px11-0218-w, lot # 75hb2020, mfg. Date: 08-2012, exp. Date: 08-2017.
Patient Sequence No: 1, Text Type: N, H10


[59123544] Patient has arthrosurface pfxl hemicap implanted ((b)(6) 2012) in conjunction with stryker's ukr implant. The implantation date of stryker components is not known. The patient presented with pain in his left knee to the clinic after 2 weeks of arthroscopy and complains that he doesn't get pain relief as expected. Surgical findings revealed advanced arthritic disease in the lateral compartment. In his report dated (b)(6) 2016, the surgeon suspects that a titanium reaction leading to metallosis is caused at the trunnion where the two arthrosurface pfxl components join. The surgeon states that there were no signs of surface wear or damage or loosening of either of the implants. However, the implant was loose at the time of revision ((b)(6) 2016).
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3004154314-2016-00014
MDR Report Key6078003
Report SourceCOMPANY REPRESENTATIVE
Date Received2016-11-03
Date of Report2016-10-04
Date of Event2016-08-24
Date Mfgr Received2016-10-04
Date Added to Maude2016-11-03
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationMEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. PHANI PUPPALA
Manufacturer Street28 FORGE PARKWAY
Manufacturer CityFRANKLIN MA 02038
Manufacturer CountryUS
Manufacturer Postal02038
Manufacturer Phone5085203003
Manufacturer G1PRIMO MEDICAL GROUP
Manufacturer Street75 MILL ST.
Manufacturer CitySTOUGHTON MA 02072
Manufacturer CountryUS
Manufacturer Postal Code02072
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameHEMICAP PATELLO-FEMORAL RESURFACING PROSTHESIS
Generic NameKNEE JOINT PATELLO-FEMORAL RESURFACING PROSTHESIS
Product CodeKRR
Date Received2016-11-03
Returned To Mfg2016-10-18
Model NumberPX02-0218 / PX02-0705-W
Lot Number75HB2020 / 75HB3020
OperatorPHYSICIAN
Device AvailabilityR
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerARTHROSURFACE, INC.
Manufacturer Address28 FORGE PARKWAY FRANKLIN MA 02038 US 02038


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2016-11-03

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.